165 related articles for article (PubMed ID: 26095604)
1. Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts.
Bassig BA; Shu XO; Koh WP; Gao YT; Purdue MP; Butler LM; Adams-Haduch J; Xiang YB; Kemp TJ; Wang R; Pinto LA; Zheng T; Ji BT; Hosgood HD; Hu W; Yang G; Zhang H; Chow WH; Kim C; Seow WJ; Zheng W; Yuan JM; Lan Q; Rothman N
Int J Cancer; 2015 Dec; 137(11):2688-95. PubMed ID: 26095604
[TBL] [Abstract][Full Text] [Related]
2. Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk.
Purdue MP; Lan Q; Hoffman-Bolton J; Hildesheim A; Callahan CL; Strickland P; Visvanathan K; Rothman N
Int J Cancer; 2019 Apr; 144(8):1780-1785. PubMed ID: 30230539
[TBL] [Abstract][Full Text] [Related]
3. Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma.
De Roos AJ; Mirick DK; Edlefsen KL; LaCroix AZ; Kopecky KJ; Madeleine MM; Magpantay L; Martínez-Maza O
Cancer Res; 2012 Sep; 72(18):4733-43. PubMed ID: 22846913
[TBL] [Abstract][Full Text] [Related]
4. Prediagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypes.
Purdue MP; Lan Q; Langseth H; Grimsrud TK; Hildesheim A; Rothman N
Int J Cancer; 2020 Jun; 146(12):3312-3319. PubMed ID: 31523805
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma.
Purdue MP; Lan Q; Martinez-Maza O; Oken MM; Hocking W; Huang WY; Baris D; Conde B; Rothman N
Blood; 2009 Sep; 114(13):2730-2. PubMed ID: 19638620
[TBL] [Abstract][Full Text] [Related]
6. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.
Purdue MP; Lan Q; Bagni R; Hocking WG; Baris D; Reding DJ; Rothman N
Cancer Res; 2011 Jul; 71(14):4898-907. PubMed ID: 21632552
[TBL] [Abstract][Full Text] [Related]
7. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
[TBL] [Abstract][Full Text] [Related]
8. Soluble B-cell activation marker of sCD27 and sCD30 and future risk of B-cell lymphomas: A nested case-control study and meta-analyses.
Hosnijeh FS; Portengen L; Späth F; Bergdahl IA; Melin B; Mattiello A; Masala G; Sacerdote C; Naccarati A; Krogh V; Tumino R; Chadeau-Hyam M; Vineis P; Vermeulen R
Int J Cancer; 2016 May; 138(10):2357-67. PubMed ID: 26684261
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis.
Rhee J; Birmann BM; De Roos AJ; Epstein MM; Martinez-Maza O; Breen EC; Magpantay LI; Levin LI; Visvanathan K; Hosgood HD; Rohan TE; Smoller SW; Bassig BA; Qi L; Shu XO; Koh WP; Zheng W; Yuan JM; Weinstein SJ; Albanes D; Lan Q; Rothman N; Purdue MP
Int J Cancer; 2023 Mar; 152(5):865-878. PubMed ID: 36151863
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
Widney D; Gundapp G; Said JW; van der Meijden M; Bonavida B; Demidem A; Trevisan C; Taylor J; Detels R; Martínez-Maza O
Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687
[TBL] [Abstract][Full Text] [Related]
11. Occupational exposure to trichloroethylene is associated with a decline in lymphocyte subsets and soluble CD27 and CD30 markers.
Lan Q; Zhang L; Tang X; Shen M; Smith MT; Qiu C; Ge Y; Ji Z; Xiong J; He J; Reiss B; Hao Z; Liu S; Xie Y; Guo W; Purdue MP; Galvan N; Xin KX; Hu W; Beane Freeman LE; Blair AE; Li L; Rothman N; Vermeulen R; Huang H
Carcinogenesis; 2010 Sep; 31(9):1592-6. PubMed ID: 20530238
[TBL] [Abstract][Full Text] [Related]
12. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
[TBL] [Abstract][Full Text] [Related]
13. Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore.
Bassig BA; Willhauck-Fleckenstein M; Shu XO; Koh WP; Gao YT; Purdue MP; Xiang YB; Adams-Haduch J; Wang R; Brenner N; Waterboer T; Michel A; Ji BT; Hosgood HD; Rabkin CS; Yang G; Wong JYY; Zhang J; Hu W; Seow WJ; Chow WH; Pawlita M; Zheng W; Yuan JM; Lan Q; Rothman N
Int J Cancer; 2018 Aug; 143(3):570-579. PubMed ID: 29574937
[TBL] [Abstract][Full Text] [Related]
14. Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.
Levin LI; Breen EC; Birmann BM; Batista JL; Magpantay LI; Li Y; Ambinder RF; Mueller NE; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1114-1123. PubMed ID: 28341757
[No Abstract] [Full Text] [Related]
15. Markers of microbial translocation and risk of AIDS-related lymphoma.
Marks MA; Rabkin CS; Engels EA; Busch E; Kopp W; Rager H; Goedert JJ; Chaturvedi AK
AIDS; 2013 Jan; 27(3):469-74. PubMed ID: 23169327
[TBL] [Abstract][Full Text] [Related]
16. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
[TBL] [Abstract][Full Text] [Related]
17. Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies.
Makgoeng SB; Bolanos RS; Jeon CY; Weiss RE; Arah OA; Breen EC; Martínez-Maza O; Hussain SK
JNCI Cancer Spectr; 2018 Dec; 2(4):pky082. PubMed ID: 30873511
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of the lymphocyte activation markers CD30 and CD27 in patients with pouchitis.
Thomas PD; Forbes A; Nicholls RJ; Ciclitira PJ
Scand J Gastroenterol; 2001 Mar; 36(3):258-64. PubMed ID: 11305512
[TBL] [Abstract][Full Text] [Related]
19. Circulating soluble CD30 and future risk of lymphoma; evidence from two prospective studies in the general population.
Vermeulen R; Hosnijeh FS; Portengen L; Krogh V; Palli D; Panico S; Tumino R; Sacredote C; Purdue M; Lan Q; Rothman N; Vineis P
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1925-7. PubMed ID: 21784955
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.
Epeldegui M; Magpantay L; Guo Y; Halec G; Cumberland WG; Yen PK; Macatangay B; Margolick JB; Rositch AF; Wolinsky S; Martinez-Maza O; Hussain SK
AIDS; 2018 Apr; 32(7):945-954. PubMed ID: 29424776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
